Comera Life Sciences (CMRA) News Today $0.0002 0.00 (0.00%) As of 08/27/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CMRA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Comera Life Sciences (NASDAQ:CMRA) & ProMetic Life Sciences (OTCMKTS:PFSCF) Head to Head ReviewAugust 21, 2025 | americanbankingnews.comTandy Leather Factory (NASDAQ:TLF) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comCarisma Therapeutics to Join Citizens JMP Life Sciences ConferenceMay 12, 2024 | msn.comComera Life Sciences Announces Sweeping Workforce TerminationJanuary 31, 2024 | msn.comComera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionJanuary 4, 2024 | finance.yahoo.comComera Life Sciences Announces Bridge Financing and Exercise of Take Private OptionJanuary 4, 2024 | finance.yahoo.comComera Life Sciences to explore strategic alternativesDecember 6, 2023 | msn.comComera Life Sciences Announces Process Exploring Strategic AlternativesDecember 6, 2023 | finance.yahoo.comComera Life Sciences Stock (NASDAQ:CMRA), Analyst Ratings, Price Targets, PredictionsNovember 26, 2023 | benzinga.comComera Life Sciences Designates Dorothy Clarke to Board of DirectorsNovember 13, 2023 | finance.yahoo.comComera Life Sciences Appoints Dorothy Clarke to Board of DirectorsNovember 13, 2023 | finance.yahoo.comComera Life Sciences GAAP EPS of -$0.10, revenue of $0.14MNovember 9, 2023 | msn.comComera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business HighlightsNovember 9, 2023 | finance.yahoo.comComera Life Sciences Advancing Subcutaneous Monoclonal Antibody FormulationsOctober 18, 2023 | finance.yahoo.comComera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery ConferenceOctober 16, 2023 | finance.yahoo.comMassive Insider Trade At Comera Life SciencesSeptember 13, 2023 | benzinga.com10% Owner At This Health Care Company Buys $1.05M of StockSeptember 12, 2023 | benzinga.comComera Life Sciences Announces the Completion of $4.1 Million Private PlacementSeptember 12, 2023 | finance.yahoo.comComera Study Shows Caffeine’s Ability to Reduce Viscosity in AntibodiesAugust 16, 2023 | finance.yahoo.comComera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing CapabilitiesAugust 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business HighlightsAugust 10, 2023 | finance.yahoo.comComera Life Sciences Boosts SQore Platform PatentsAugust 8, 2023 | finance.yahoo.comComera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ PlatformAugust 8, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementAugust 2, 2023 | finance.yahoo.comComera Life Sciences Announces $4.1 Million Private PlacementAugust 1, 2023 | finance.yahoo.comComera Partners with Quality Chemical Laboratories to Strengthen Supply ChainJuly 24, 2023 | finance.yahoo.comCMRA Comera Life Sciences Holdings, Inc.July 15, 2023 | seekingalpha.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsMay 11, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business HighlightsMay 11, 2023 | finance.yahoo.comComera Life Sciences to Participate in Four Upcoming ConferencesApril 27, 2023 | finance.yahoo.comComera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient TechnologyApril 3, 2023 | finance.yahoo.comComera Life Sciences GAAP EPS of -$0.18, revenue of $0.15MMarch 16, 2023 | msn.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsMarch 16, 2023 | finance.yahoo.comComera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business HighlightsMarch 16, 2023 | finance.yahoo.comComera Life Sciences shares details of recent private placementJanuary 31, 2023 | proactiveinvestors.comComera Life Sciences to Present at 22nd Annual PepTalk ConferenceJanuary 12, 2023 | finance.yahoo.comComera Life Sciences to Present at Upcoming Biotech Showcase Investor ConferenceJanuary 5, 2023 | finance.yahoo.comComera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq RulesJanuary 4, 2023 | finance.yahoo.comComera Life Sciences Holdings, Inc. (NASDAQ:CMRA) insiders are still down US$76k after purchasing last year, recent gain helped regain some lossesDecember 1, 2022 | uk.finance.yahoo.comComera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNovember 18, 2022 | finance.yahoo.comComera Life Sciences Reports Financial Results for Third Quarter 2022 and Business HighlightsNovember 10, 2022 | finance.yahoo.comComera Life Sciences Appoints Janice Marie McCourt as Chief Business OfficerNovember 9, 2022 | finance.yahoo.comComera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 StudyOctober 18, 2022 | finance.yahoo.comComera Life Sciences Expands Woburn OperationsOctober 4, 2022 | finance.yahoo.comComera Life Sciences Holdings Inc.September 14, 2022 | wsj.comComera Life Sciences Holdings Spikes 38%September 13, 2022 | nasdaq.comComera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business SolutionsAugust 31, 2022 | finance.yahoo.comComera Life Sciences GAAP EPS of -$1.14, revenue of $0.15MAugust 12, 2022 | seekingalpha.comComera Life Sciences to Present Topline Results of SEQURUS-2 Study at 14th Annual Bioprocessing SummitAugust 11, 2022 | finance.yahoo.comComera Life Sciences Provides Business Highlights and Reports Financial Results for the Second Quarter 2022August 10, 2022 | finance.yahoo.com Get Comera Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMRA Media Mentions By Week CMRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRA News Sentiment▼0.001.03▲Average Medical News Sentiment CMRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRA Articles This Week▼00▲CMRA Articles Average Week Get the Latest News and Ratings for CMRA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Comera Life Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies VRPX News Today AIMDW News Today BCTXW News Today GDTC News Today ENGNW News Today FBIOP News Today GLPG News Today GOVXW News Today INDV News Today INCR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Comera Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access